Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

398 ARTÍCULOS , VIENDO DEL 346 AL 360

Comparison of Cognitive Intervention Strategies for Older Adults With Mild to Moderate Alzheimer's Disease: A Bayesian Meta-analytic Review

Liang JH, Li JY, Jia RX, Wang YQ, Wu RK, Zhang HB, Hang L, Xu Y, Pan CW.

J Am Med Dir Assoc. 2019 Mar;20(3):347-355. doi: 10.1016/j.jamda.2018.09.017. Epub 2018 Nov 17.

Efficacy of Cognitive Rehabilitation in Alzheimer Disease: A 1-Year Follow-Up Study

Germain S, Wojtasik V, Lekeu F, Quittre A, Olivier C, Godichard V, Salmon E.

J Geriatr Psychiatry Neurol. 2019 Jan;32(1):16-23. doi: 10.1177/0891988718813724. Epub 2018 Nov 26.

Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer's disease

Camins A, Ettcheto M, Busquets O, Manzine PR, Castro-Torres RD, Beas-Zarate C, Verdaguer E, Sureda FX, Bulló M, Olloquequi J, Auladell C, Folch J.

Expert Opin Investig Drugs. 2019 Jan;28(1):93-97. doi: 10.1080/13543784.2019.1552677. Epub 2018 Dec 1.

Tacrines as Therapeutic Agents for Alzheimer's Disease. IV. The Tacripyrines and Related Annulated Tacrines

Bartolini M, Marco-Contelles J.

Chem Rec. 2019 May;19(5):927-937. doi: 10.1002/tcr.201800155. Epub 2018 Nov 29.

New approaches for the treatment of Alzheimer's disease

Fish PV, Steadman D, Bayle ED, Whiting P.

Bioorg Med Chem Lett. 2019 Jan 15;29(2):125-133. doi: 10.1016/j.bmcl.2018.11.034. Epub 2018 Nov 19.

Reconsideration of Anticholinesterase Therapeutic Strategies against Alzheimer's Disease

Wang H, Zhang H.

ACS Chem Neurosci. 2019 Feb 20;10(2):852-862. doi: 10.1021/acschemneuro.8b00391. Epub 2018 Dec 6.

Feasibility and Impact of a Multicomponent Exercise Intervention in Patients With Alzheimer's Disease: A Pilot Study

Borges-Machado F, Ribeiro Ó, Sampaio A, Marques-Aleixo I, Meireles J, Carvalho J.

Am J Alzheimers Dis Other Demen. 2019 Mar;34(2):95-103. doi: 10.1177/1533317518813555. Epub 2018 Dec 9.

Translating the biology of aging into novel therapeutics for Alzheimer disease

Hara Y, McKeehan N, Fillit HM.

Neurology. 2019 Jan 8;92(2):84-93. doi: 10.1212/WNL.0000000000006745. Epub 2018 Dec 7.

Structure-Based Survey of the Binding Modes of BACE1 Inhibitors

Hu H, Chen Z, Xu X, Xu Y.

ACS Chem Neurosci. 2019 Feb 20;10(2):880-889. doi: 10.1021/acschemneuro.8b00420. Epub 2018 Dec 27.

Alzheimer's disease: understanding homeostasis deregulation to foster development of effective therapies

Nisticò R, Peineau S.

Pharmacol Res. 2019 Jan;139:467-468. doi: 10.1016/j.phrs.2018.12.011. Epub 2018 Dec 13.

The ketogenic diet as a potential treatment and prevention strategy for Alzheimer's disease

Broom GM, Shaw IC, Rucklidge JJ.

Nutrition. 2019 Apr;60:118-121. doi: 10.1016/j.nut.2018.10.003. Epub 2018 Oct 10.

Efficacy and safety of idalopirdine for Alzheimer's disease: a systematic review and meta-analysis

Matsunaga S, Fujishiro H, Takechi H.

Int Psychogeriatr. 2019 Nov;31(11):1627-1633. doi: 10.1017/S1041610218002156. Epub 2018 Dec 18.

Repetitive Transcranial Magnetic Stimulation Improves Executive Function and Music Rhythm

Padala KP, Hunter CR, Parkes CM, Lensing SY, Padala PR.

J Neuropsychiatry Clin Neurosci. 2019 Spring;31(2):178-180. doi: 10.1176/appi.neuropsych.18100224. Epub 2018 Dec 18.

Stem cell therapy in Alzheimer's disease: possible benefits and limiting drawbacks

Alipour M, Nabavi SM, Arab L, Vosough M, Pakdaman H, Ehsani E, Shahpasand K.

Mol Biol Rep. 2019 Feb;46(1):1425-1446. doi: 10.1007/s11033-018-4499-7. Epub 2018 Dec 18.

Alzheimer's disease therapeutic candidate SAK3 is an enhancer of T-type calcium channels

Fukunaga K, Izumi H, Yabuki Y, Shinoda Y, Shioda N, Han F.

J Pharmacol Sci. 2019 Feb;139(2):51-58. doi: 10.1016/j.jphs.2018.11.014. Epub 2018 Dec 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias